Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05731648
Other study ID # Neurosurgery and spasticity
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 1, 2023
Est. completion date April 1, 2025

Study information

Verified date February 2023
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Spasticity can result from a variety of causes in neural axis from which most common are cerebral palsy, strokes, cerebral haemorrhage, multiple sclerosis , traumatic brain injury and spinal cord injury and underlying mechanism is broadly due to decrease inhibition of the spinal network. Clinical evaluation for spasticity involve series of clinical assessment , physical examination , and neurophysiological testing. quantitative evaluation of spasticity can be measured using modified Ashworth scale which is the most widely used clinical spasticity scale and can be used for various clinical conditions causing spasticity


Description:

Currently, the management of spasticity spans in a continuum between non-invasive and invasive intervention to modulate its effects and improve patients' Quality of life and when spasticity becomes excessive and aggravates disability, functional neurosurgery can be a resource. Neurosurgical procedures for management of spasticity are classified according to whether their effect is generalized or focal and whether they are reversible or irreversible. Procedures include intrathecal baclofen pump , spinal cord stimulation and lesioning techniques peripheral nerves , dorsal roots , spinal cord or dorsal root entry zone


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date April 1, 2025
Est. primary completion date March 1, 2025
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patients with spasticity refractory to medical treatment (most commonly administered oral medications for managing spasticity are diazepam, dantrolene sodium, and baclofen) and physiotherapy Exclusion Criteria: - Patients unfit for neurosurgical intervention

Study Design


Intervention

Device:
Intrathecal balofen pump
Management of spasticity

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (2)

Hinderer SR, Dixon K. Physiologic and clinical monitoring of spastic hypertonia. Phys Med Rehabil Clin N Am. 2001 Nov;12(4):733-46. — View Citation

Kheder A, Nair KP. Spasticity: pathophysiology, evaluation and management. Pract Neurol. 2012 Oct;12(5):289-98. doi: 10.1136/practneurol-2011-000155. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate safety and efficacy of neurosurgical procedures Rate of complication ( infection , bleeding , Device Malware ) 6 month
Primary Evaluate Changes in Modified Ashworth scale 0: No increase in muscle tone
1: Slight increase in muscle tone, with a catch and release or minimal resistance at the end of the range of motion when an affected part(s) is moved in flexion or extension
1+: Slight increase in muscle tone, manifested as a catch, followed by minimal resistance through the remainder (less than half) of the range of motion
2: A marked increase in muscle tone throughout most of the range of motion, but affected part(s) are still easily moved
3: Considerable increase in muscle tone, passive movement difficult
4: Affected part(s) rigid in flexion or extension
6 month
See also
  Status Clinical Trial Phase
Recruiting NCT04310670 - Integrated Treatment in FND (Functional Neurological Disorders) N/A
Not yet recruiting NCT06346873 - Demonstrating Efficacy of JOGO for the Treatment of Tremor N/A
Active, not recruiting NCT05941702 - Body Signal Integration Training: A Case Series N/A
Recruiting NCT06084325 - The Role of Oxytocin and Interoception in Functional Neurological Disorder
Active, not recruiting NCT05581810 - Rehabilitation for Functional Memory Symptoms After Concussion N/A
Completed NCT03325374 - BLB Study Back or Leg Pain and Bladder Symptoms Study
Recruiting NCT06149728 - Pain Assessment and Transcranial Magnetic Stimulation Tolerability in Patients With a Functional Neurological Disorder
Terminated NCT02764476 - Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder N/A
Not yet recruiting NCT06362161 - Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
Active, not recruiting NCT03857347 - Psychoeducation Group Intervention for FND N/A
Terminated NCT03731078 - Pilot Study of Cognitive Behavioral Therapy-Informed Physical Therapy Intervention in Functional Neurological Disorders
Not yet recruiting NCT06422819 - Clinical Evaluation of HRV Biofeedback in Functional Neurological Disorders Compared to Placebo N/A
Completed NCT05634486 - Efficacy of the Multidisciplinary Treatment to the Quality of Life of With Functional Movement Disorders N/A
Not yet recruiting NCT05723276 - Psilocybin in Functional Neurological Disorder N/A
Recruiting NCT06257069 - Tremor Retrainer Software Application for Functional Tremor N/A
Completed NCT04942600 - Behavioural and Electrophysiological Effects of rTMS in Functional Neurological Disorders N/A
Recruiting NCT06105996 - ADIE-FS - Aligning Dimensions of Interoceptive Experience in Patients With Functional Seizures N/A